Jordan Harbinger avatar

Dexa/Jordan Harbinger

Learn more
Published Aug 9, 2022

709: John Abramson | How Big Pharma Broke American Health Care

Harvard Medical School's John Abramson unveils the disturbing realities of Big Pharma's influence on American healthcare, highlighting systemic corruption, manipulative drug data, and exorbitant costs that prioritize profit over public health. He advocates for comprehensive reforms and increased public awareness to challenge the paradox of costly yet declining US health outcomes.
Episode Highlights
The Jordan Harbinger Show logo

Topics covered

Popular Clips

Questions from this episode

Episode Highlights

  • Life Expectancy

    The United States faces a paradox where high healthcare spending does not translate into better life expectancy. highlights that despite spending $4 trillion annually on healthcare, Americans live 5.3 years less than citizens of other wealthy nations 1. This decline in life expectancy is alarming, especially when considering that the US spends $1.6 trillion more than these countries. points out the disturbing trend, noting, "Our life expectancy is, I guess, you would say shrinking in comparison to other countries or possibly, actually just shrinking."

    Our life expectancy is, I guess, you would say shrinking in comparison to other countries or possibly, actually just shrinking.

    ---

    argues that the healthcare system is not effectively oriented towards improving health outcomes, which is evident in the country's declining life expectancy 1.

       

    Resource Allocation

    The misallocation of healthcare resources in the US is a significant issue, with funds directed towards costly treatments rather than preventive care. explains that $20 billion could be saved annually by rationalizing insulin use, yet the focus remains on expensive drugs rather than lifestyle changes that could prevent diseases like type 2 diabetes 2. This misdirection is a form of wealth transfer, benefiting pharmaceutical companies at the expense of public health. notes, "All the money goes into the pockets of the investors and the executives at the drug companies, instead of going to people who actually need lifestyle help."

    All the money goes into the pockets of the investors and the executives at the drug companies, instead of going to people who actually need lifestyle help.

    ---

    emphasizes the need for a national program to allocate medical research funding effectively, ensuring that resources are used to produce the most positive societal outcomes 2.

Related Episodes